Anti-Retrovirals in Africa, not a distant dream

by Medindia Content Team on  February 9, 2006 at 3:08 PM General Health News
RSS Email Print This Page Comment bookmark
Font : A-A+

Anti-Retrovirals in Africa, not a distant dream
Ranbaxy Laboratories (India) has entered into a joint venture with a South African company that will support Ranbaxy's key agenda of enabling antiretroviral drugs in Africa. A joint venture between Ranbaxy and South Africa based Community Investment Holdings has been signed, that will give authority for this company to sell the drugs in Africa. The CEO of Ranbaxy South Africa, Desmond Brothers, conveyed that this venture will permit the company to make the drugs available at a low cost.

Ranbaxy will retain 70% of the venture, called Sonke Pharmaceuticals, in charge of marketing the products under the brand name 'Sonke'. Governments, retail pharmacists, HIV/AIDS disease management companies, nongovernmental organizations and independent community treatment organizations in South Africa, Botswana and Namibia, will be the contact points for sales of the antiretroviral drugs.


Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Sleep Disorder 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

Advertisement

News Category

News Archive